Fig. 3
Distribution of patients by DAS28 ESR and DAS28 CRP classes at start of biologic treatment under analysis, and after 6Â months and 1Â year after treatment start
Fig. 3 | BMC Rheumatology
Distribution of patients by DAS28 ESR and DAS28 CRP classes at start of biologic treatment under analysis, and after 6Â months and 1Â year after treatment start